ARK Sold Almost 400,000 Shares of CRISPR Therapeutics. Is Cathie Wood Worried?

According to the 13F filing with the Securities and Exchange Commission dated Nov. 12, 2025, ARK Investment Management sold ...

CRISPR Therapeutics's Options Frenzy: What You Need to Know

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
TipRanks on MSN

Crispr Therapeutics’ Long-term Study on CAR T Therapies: A Market Game Changer?

Crispr Therapeutics (($CRSP)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled A Long-term Follow-up ...
Barron's

CRISPR Therapeutics AG

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its ...
MarketWatch

Biopharmaceuticals Global Market Overview 2025: Technological Advancements like CRISPR Gene Editing and NGS Fueling Innovations - Global Forecasts 2020-2030 ...

The "Biopharmaceuticals - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is ...